0001209191-21-014690.txt : 20210226 0001209191-21-014690.hdr.sgml : 20210226 20210226160707 ACCESSION NUMBER: 0001209191-21-014690 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210224 FILED AS OF DATE: 20210226 DATE AS OF CHANGE: 20210226 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Arbuckle Stuart A CENTRAL INDEX KEY: 0001557290 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-19319 FILM NUMBER: 21688757 MAIL ADDRESS: STREET 1: VERTEX PHARMACEUTICALS INCORPORATED STREET 2: 130 WAVERLY ST. CITY: CAMBRIDGE STATE: MA ZIP: 02139 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: VERTEX PHARMACEUTICALS INC / MA CENTRAL INDEX KEY: 0000875320 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 043039129 STATE OF INCORPORATION: MA FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 50 NORTHERN AVENUE CITY: BOSTON STATE: MA ZIP: 02210 BUSINESS PHONE: 6173416393 MAIL ADDRESS: STREET 1: 50 NORTHERN AVENUE CITY: BOSTON STATE: MA ZIP: 02210 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2021-02-24 0 0000875320 VERTEX PHARMACEUTICALS INC / MA VRTX 0001557290 Arbuckle Stuart A C/O VERTEX PHARMACEUTICALS INCORPORATED 50 NORTHERN AVENUE BOSTON MA 02210 0 1 0 0 EVP, Chief Commercial Officer Common Stock 2021-02-24 4 F 0 2898 217.57 D 44737 D Common Stock 2021-02-25 4 S 0 380 211.39 D 44357 D Common Stock 2021-02-25 4 S 0 900 212.52 D 43457 D Common Stock 2021-02-25 4 S 0 1400 213.55 D 42057 D Common Stock 2021-02-25 4 S 0 400 214.32 D 41657 D Common Stock 2021-02-25 4 S 0 300 215.62 D 41357 D Common Stock 2021-02-25 4 S 0 254 216.57 D 41103 D Common Stock 140 I 401(k) Transaction made pursuant to Mr. Arbuckle's company approved trading plan under Rule 10b5-1. Open market sales reported on this line occurred at a weighted average price of $211.39 (range $210.76 to $211.68). Mr. Arbuckle undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. Open market sales reported on this line occurred at a weighted average price of $212.52 (range $212.05 to $213.02). Open market sales reported on this line occurred at a weighted average price of $213.55 (range $213.09 to $214.08). Open market sales reported on this line occurred at a weighted average price of $214.32 (range $214.10 to $214.62). Open market sales reported on this line occurred at a weighted average price of $215.62 (range $215.37 to $215.84). Open market sales reported on this line occurred at a weighted average price of $216.57 (range $216.50 to $216.62). /s/ Sabrina Yohai, Attorney-in-Fact 2021-02-26